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Abstract
The hip joint can often be affected by extra- and intra-articular pathologies 
including gluteal tendinopathy, femoroacetabular impingement syndrome and hip 
osteoarthritis. Understanding alterations associated with these pathologies will 
provide greater insight into developing and optimising patient-specific treatments. 
A number of biomechanical and neuromuscular impairment are associated with 
Femoracetabular impingement (FAI), gluteal tendinopathy (GT) and hip osteo-
arthritis (OA) conditions including but not limited to muscle weakness, altered 
postural control, restricted range of motion and altered tendon/joint loading. These 
alterations can present differently in sub-groups of patients and result directly 
from the pathological process and/or indirectly from pain and its consequences 
(e.g. reduced activity). These impairments are often targets for conservative inter-
ventions but there is currently little clinical trial evidence to show that treatments 
can modify these impairments. Clinical trial evidence does, however, support 
conservative treatment options for each of the pathologies reviewed. Clinical 
outcome tools used to evaluate the effects of treatment and track change over time 
are recommended.
Keywords: hip osteoarthritis, femoroacetabular impingement, gluteal tendinopathy, 
exercise, biomechanics, outcome measurement
1. Introduction
This chapter will present contemporary conservative considerations for the 
management of extra- and intra-articular hip pathologies including gluteal 
tendinopathy (GT), femoroacetabular impingement (FAI) syndrome and hip 
osteoarthritis (OA). The clinical presentation of hip pathology is frequent and can 
be complex. Over the past decade research has uncovered new insights into biome-
chanical alterations associations with GT, FAI and hip OA that enables clinicians to 
better understand the condition and management options. We provide an overview 
of the most significant discoveries as well as unpack the evidence for effective 
conservative management. Clinical outcome tools used to evaluate the effectiveness 
of treatments and track change over time in these hip conditions are reviewed.
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2. Gluteal tendinopathy
Gluteal tendinopathy, also referred to as “greater trochanteric pain syndrome”, is 
a chronic, debilitating musculoskeletal condition affecting the tendinous insertion 
of the gluteus medius and/or minimus muscles at or above their attachments into 
the greater trochanter of the femur [1]. The hallmark features of this extra-articular 
hip condition are pain and tenderness to palpation at or around the region of the 
greater trochanter [1–3]. Prevalence rates of GT have been reported at 18% of those 
aged 50–79 years presenting to general practitioners [3]. Individuals with GT are 
most frequently over the age of 40 years [4] and typically experience pain during 
walking, stair climbing and/or lying on the affected side [1–3].
2.1 Biomechanical considerations in gluteal tendinopathy
2.1.1 Important anatomical and biomechanical considerations
The trochanteric bursae were previously considered the primary structure 
implicated in greater trochanteric pain [5]. However, new evidence from magnetic 
resonance imaging (MRI) [6, 7], ultrasound [8, 9] and surgical case series’ [7, 10] 
has led to a contemporary understanding of the pathological mechanisms of the 
gluteal tendons underpinning greater trochanter pain. This progressive understand-
ing of tendon involvement has necessitated important advances regarding biome-
chanical considerations associated with GT.
The gluteal tendons are vulnerable to anatomical compression against the (i) 
underlying greater trochanter, as they wrap over the borders of its bony facets into 
their respective insertions [11], and (ii) from the overlying iliotibial band (ITB), 
particularly as the hip moves into adduction. With increasing adduction of the 
femur relative to the pelvis, the insertion of the gluteus minimus and medius mus-
cles on the greater trochanter are moved away from their respective origins on the 
ilium, placing longitudinal tensile and transverse tensile strain through the tendon 
fibres passing over the greater trochanter. In addition, the ITB exerts progressively 
higher compressive forces at the greater trochanter as the hip moves into hip adduc-
tion (4 N at 0°, increased by nine-fold to 36 N at 10° and 106 N at 40°) [12], which 
has direct consequences for gluteal tendon loading. Excessive tensile and compres-
sive loads are accepted to be detrimental for tendon health and particularly relevant 
for the development and perpetuation of tendinopathy [13]. Thus, dynamic control 
of hip adduction is pertinent in the assessment and management of GT [14].
2.1.2 Hip abductor muscle weakness and clinical relevance to loading biomechanics
Like other tendinopathies, muscle weakness is a feature of GT [15]. Strength 
deficiencies of 32% of the hip abductor muscles on the symptomatic hip and 
23% on the asymptomatic hip have been identified in individuals with clinically 
and MRI diagnosed GT compared to age- and sex-comparable controls [15]. The 
primary functional role of the hip abductor muscles is to maintain alignment of 
the pelvis in the frontal plane during gait, to eccentrically control the provocative 
position of hip adduction [16]. The relationship between hip adduction angle and 
hip abductor tendon loading in GT highlights the importance of abductor muscle 
strength for adequate eccentric control of hip adduction in this patient group [16]. 
Clinicians often evaluate hip abductor function by visually evaluating a patient’s 
ability to maintain and control position of the pelvis in single leg stance (SLS) [17]. 
Further, SLS kinematics are considered relevant for control of single leg loading 
during gait.
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Data from three-dimensional motion capture analysis identified that individu-
als with GT exhibit greater lateral pelvic shift and hip adduction in preparation for 
SLS, and more hip adduction and less contralateral pelvic elevation during SLS in 
the frontal plane when compared to age and sex matched controls [18] (Figure 1). 
Though these findings may be, in part, explained by hip abductor muscle weakness 
[18], they also provide important insight into why single leg stance is provocative 
for many individuals with GT. Specifically, the increased potential tensile and com-
pressive load through the gluteal tendons as the muscles work to control the position 
of the pelvis on the femur, is a likely relevant mechanism for tendon overload and 
pain.
2.1.3 Gait biomechanics
To date, only one study has evaluated walking kinematics and kinetics in indi-
viduals with GT compared to healthy controls. In contrast to pain-free controls, 
individuals with GT exhibit a significantly greater external hip adduction moment 
during the stance phase of walking [19] and during stair climbing [20]. These 
observations are thought to have distinct clinical relevance, given the external hip 
adduction moment represents an internal hip abductor moment contributed to 
by active and passive tension in the primary hip abductor muscles (i.e. the gluteus 
minimus and medius) [21]. Of importance to clinicians who use visual observa-
tion as part of their assessment in GT, contralateral pelvic drop is associated with 
a greater magnitude of the external hip adduction moment [19]. While data has 
shown that individuals with GT exhibit greater contralateral pelvic drop during 
late stance compared to controls, with implications for hip adduction angles and 
tendon loading, this between-group difference during walking was small on aver-
age (1.4 degrees), with questionable clinical relevance [19]. This small mean dif-
ference may be explained by variation in walking strategies utilised by participants 
in the GT group. A secondary analysis identified distinct subgroups in those with 
GT [19]. This novel and clinically relevant observation highlights that people with 
GT can compensate for hip abductor weakness in different ways, which coincide 
with compensations reported in individuals with intra-articular hip pain [22] and 
Figure 1. 
In preparation for single leg stance (SLS) individuals with gluteal tendinopathy exhibit greater lateral pelvic 
shift over the stance limb (and subsequently greater hip adduction angle) and maintain a position of single leg 
stance with greater contralateral pelvic drop (and subsequently hip adduction angle).
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with extra-articular hip pathology, such as GT [19]. Specifically, two subgroups 
were identified in those with GT: (1) individuals demonstrating an uncompensated 
Trendelenburg (contralateral pelvic drop and associated contralateral trunk lean 
where no compensation is made for hip abductor weakness and the position of the 
pelvis cannot be maintained in the frontal plane); and (2) individuals demonstrat-
ing a compensated Trendelenburg (ipsilateral trunk lean in an attempt to bring 
the centre of mass closer to the base of support, resulting in reduced hip abductor 
muscle requirements and maintenance of the position of the pelvis in the frontal 
plane) (Figure 2).
2.2 Non-surgical management for gluteal tendinopathy
Evidence for the management of gluteal tendinopathy is continuing to emerge. 
Historically, as a result of limited understanding of the pathology and associated 
impairments in GT, treatment had been simplistic, targeting symptoms or the pre-
sumed pathological involvement of the trochanteric bursae. More recently, drawing 
from contemporary evidence in other tendinopathies and an understanding of 
tendon structure and function, exercise interventions for GT have been refined and 
are beginning to be tested in randomised controlled trials with promising results. 
The most recent systematic review at the time of print concluded that poor quality 
and insufficient data prevented any conclusions to be drawn regarding optimal 
treatment for greater trochanteric pain syndrome including GT [23]. Studies in this 
review and others describe interventions of surgical tendon repair, ITB release and 
bursectomy, corticosteroid injection, home exercise, shock wave therapy and dry 
needling [23]. Issues arise when interpreting the collective results of these studies 
with respect to GT, as the samples are diverse with respect to co-morbidities (e.g. 
hip OA, lumbar pathology), symptom duration, and most importantly, clinical and 
Figure 2. 
Subgroups have been identified in individuals with gluteal tendinopathy during walking [19]. Some individuals 
walk with an uncompensated Trendelenburg (contralateral pelvic drop and trunk lean, increasing the centre of 
mass from the hip joint centre and subsequently influencing the magnitude of the external adduction moment), 
while some adopt a compensated Trendelenburg (ipsilateral trunk lean, bringing the centre of mass closer to the 
hip joint centre, a strategy to reduce the magnitude of the external hip adduction moment and requirement for 
the hip abductor muscles, maintaining alignment of the pelvis in the frontal plane).
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imaging diagnosis specific to GT. Further, very few interventions have been evalu-
ated in randomised controlled trials.
The strong focus on corticosteroid injection in GT arises from the original 
theory that trochanteric pain was due to an inflammatory process within the 
trochanteric bursae. However, the effectiveness and safety of the use of cortico-
steroid injection in tendinopathy is debatable. Evidence from a high quality sys-
tematic review pooling 41 studies evaluating the effect of corticosteroid injection 
on upper limb, patella and Achilles tendinopathies suggests that while cortisone 
improves symptoms in the short term, there are no long term effects at 13–26 weeks 
or ≥ 52 weeks [24]. While these findings cannot be directly inferred to GT, a similar 
attenuation effect of symptom relief in response to corticosteroid injection has been 
demonstrated in three clinical trials in greater trochanteric pain syndrome [25–27], 
questioning the efficacy of corticosteroid use in GT.
Given that tendon is a metabolically active tissue that maintains its integrity in 
response to tensile loading, exercise and load modification appear to be important 
aspects of effective treatment in management of tendinopathy [28]. In order to 
modify tendon load in the lower limb, addressing lower limb biomechanics and 
neuromuscular control is considered an effective clinical strategy [14]. Specific to 
GT, modifying compressive load at the greater trochanter is thought to be particu-
larly relevant [5, 27]. Load modification can be achieved my reducing time spent in 
sustained positions of hip adduction where the gluteal tendons are vulnerable to 
compressive loading against the greater trochanter below and iliotibial band above 
(e.g. sitting cross legged, standing ‘hanging on one hip’, sleeping on the affected 
side or the unaffected side with the affected limb crossing into hip adduction) or 
dynamic adduction during gait [14]. The latter is thought to be best achieved by 
including (1) functional weight bearing hip abductor muscle exercises (e.g. bridg-
ing, squat, side-stepping) focusing on pelvic alignment control in the frontal and 
transverse planes double to single leg loading and by focusing on (2) hip abductor 
strengthening exercises to address muscle weakness and increase loading capacity 
of the gluteal tendons [15] (e.g. side-stepping with band, reformer based sliders). 
A fundamental principle in tendinopathy management which must be applied in 
this exercise prescription context is that of progressive graduated overload to enable 
tendon remodelling and adaptation [14]. It is essential that exercise difficulty is 
gradually increased as tolerated to ensure optimal muscle activation to enable gains 
in muscle strength and function without significant aggravation of pain. Finally 
specific to the context of GT, (3) motor control of the entire hip abductor muscle 
mechanism thought to be important to reduce overactivity of tensor fascia lata (and 
subsequent ITB tension) relative to the deeper segments of the gluteus minimus and 
medius muscles [29] to facilitate gluteal tendon tensile loading and avoid compres-
sive loads, known to be detrimental to tendon health. Patient tactile feedback over 
the tensor fascia lata and gluteal muscles is thought to be a useful clinical strategy to 
address this goal [14].
A recent clinical trial demonstrated that a progressive exercise program incor-
porating functional training, targeted strengthening and dynamic motor control 
of the pelvis, delivered with patient education over 8-weeks under supervision 
of a physiotherapist, was superior to a wait-and-see approach or corticosteroid 
injection [27]. These results are promising and contribute to the body of evidence 
for treatment of GT. Importantly, they also add to the contemporary conversation 
that emphasises the need for patient education in management. As outlined, it is 
evident that hip abductor muscle strength, biomechanical and neuromuscular pat-
terns be considered in the assessment and management of GT. However, data from 
individuals with GT highlights that the kinematic presentation of GT is heteroge-
neous [19, 20]. Thus a ‘one size fits all’ approach to assessment and management 
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is unlikely to be effective. Clinicians should evaluate patients who present with 
GT with respect to specific biomechanical and neuromuscular impairments, and 
tailor treatment and load modification based on the principles of tendinopathy 
treatment.
3. Femoroacetabular impingement syndrome
FAI syndrome is a motion related condition of the hip joint and is associated 
with hip pain and impaired function in younger active adults [30]. FAI is character-
ised by abnormally shaped hip bones (i.e. head of femur and/or acetabulum), which 
can lead to mechanical impingement during movement [30]. Repetitive mechanical 
impingement is thought to lead to chondral stresses that cause irreversible struc-
tural pathology [31]. FAI syndrome is considered a principal determinant of future 
development of hip osteoarthritis [32].
3.1 Biomechanical considerations in femoroacetabular impingement syndrome
3.1.1 Hip joint biomechanics
Evidence for altered hip joint biomechanics during movement in individuals 
with FAI syndrome is mounting [33]. Gait has been well studied in this population. 
Findings from systematic reviews [31, 33] and empirical studies provide moderate 
evidence for less sagittal plane hip range of motion (ROM) [34], primarily driven by 
a lower peak hip extension angle [35], during gait in individuals with FAI syndrome 
compared to healthy controls. Lower peak hip internal rotation angle [35, 36] and 
lower peak hip external rotation joint torque [35] have also be reported during 
stance in FAI syndrome compared to healthy controls. However, the biomechanical 
adaptations exhibited by individuals with FAI syndrome during gait are generally 
small on average, and consequently of uncertain clinical significance.
Hip joint biomechanics during squatting [37–39] in FAI syndrome also differs 
only subtly from individuals without pain or FAI morphology. Though some studies 
report that individuals with FAI syndrome are unable to squat as deep as controls 
[37, 39], hip flexion range is not significantly reduced during task completion 
[37–39]. Individuals with FAI syndrome place the hip in a more adducted position 
during squatting [38] and step ascent [40], which may be secondary to hip abductor 
muscle weakness commonly reported in FAI syndrome cohorts [41]. Biomechanical 
comparisons during these more demanding tasks targeting positions of impinge-
ment (i.e. squatting and step ascent) have extended knowledge regarding altered 
hip joint biomechanics in individuals with FAI syndrome. Nevertheless, the impli-
cations of these alterations, including any relationship with pain and/or function 
and/or joint structure remain unclear.
3.1.2 Biomechanics of adjacent segments
Individual variation in movement strategy and interaction between adjacent 
body segments (i.e. pelvis, trunk) may account for the small between-group 
differences observed in hip joint biomechanics when comparing individuals with 
FAI syndrome to healthy controls. Failure to consider such factors may explain 
the modest effects of conservative treatment [42] and the unrestored hip function 
observed post-operatively [36]. Reduced sagittal plane pelvis range of motion has 
been identified during squatting in FAI syndrome compared to healthy controls 
7Contemporary Non-Surgical Considerations in the Management of People…
DOI: http://dx.doi.org/10.5772/intechopen.81821
[39], and has been proposed as a risk factor for symptom presentation [43]. Greater 
anterior pelvic tilt has also been reported in FAI syndrome during squatting [37] 
and step descent [44] compared to healthy controls. This biomechanical alteration 
may be counterproductive for pathology since an increase in anterior pelvic position 
will promote hip flexion and thus impingement.
Few studies have considered pelvic and trunk control in the frontal plane despite 
the implications for hip joint loading [45]. Control of frontal plane pelvic alignment 
during single leg support is necessary to prevent movement into impingement. 
Pain and/or hip abductor muscle weakness, both features of FAI syndrome, could 
hinder control of the pelvis in the frontal plane. On the other hand, altered frontal 
plane control of the trunk may moderate provocative hip joint contact forces (i.e. 
reduced demand on hip abductor muscles), and has been observed in cohorts with 
hip osteoarthritis [22, 46]. Recent findings from a step ascent task corroborate that 
control of adjacent segments may play an important role in symptom management 
in FAI syndrome [40]. When individuals with FAI syndrome were sub-grouped 
based on trunk and pelvis dominant strategies, those who exhibited lateral trunk 
lean and maintained neutral pelvis alignment reported no pain and prevented the 
hip from moving towards an impinging position. It is reasonable to suggest that this 
strategy may alleviate load on the abnormal hip joint structures. In direct contrast 
to this, 86% of participants who exhibited poor pelvis control, inherently moving 
the hip into an impinging position, reported moderate levels of pain [40]. Control 
of—and interaction between—adjacent body segments may play an important 
role in symptomatic and structural preservation or deterioration in FAI syndrome. 
Further, altered hip joint function remains unresolved post-operatively [36], 
suggesting that a hip-only treatment focus may be misguided. Functional biome-
chanics is modifiable, and could be changed by conservative interventions and 
rehabilitation programs [47].
3.1.3 Patient subgrouping
FAI syndrome is a complex condition [48] with no common pathological 
pathway [30]. Patient presentation is heterogeneous, which may explain the modest 
treatment effects [42]. Different biomechanical strategies are used by separate 
subgroups of participants to perform a task [38, 49], albeit some more advanta-
geous than others for symptoms and function. As with established hip OA [50], no 
conservative treatment is likely to be effective for all individuals with FAI syn-
drome. Maximum efficacy will only be attained with interventions catered to the 
individual. More research must be done to improve understanding of the patient-
specific biomechanical alterations associated with FAI syndrome in order to better 
manage the disease and its consequences.
3.1.4 Implications for joint structure
Biomechanical alterations in individuals with FAI syndrome are subtle but 
may relate to enhanced protection for the hip, albeit with possible long-term 
consequences. It comes as no surprise that individuals with FAI syndrome exhibit 
less prominent biomechanical alterations than individuals with structural damage 
and hip OA [51]. Individuals with FAI syndrome have less severe morphological 
deformities and accordingly, exhibit more subtle biomechanical modifications. 
The absence of longitudinal studies means that it is not known whether these small 
biomechanical alterations are precursors to the larger deviations observed in those 
with established hip OA.
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3.2 Non-surgical management for femoroacetabular impingement syndrome
Arthroscopic hip surgery is the most common treatment for FAI syndrome [52]. 
Despite a dramatic upsurge in the number of surgeries performed over the past 
decade [52], surgical intervention for FAI syndrome does not completely restore 
hip joint function to that of healthy controls [36] or uniformly improve pain [53], 
despite correction of the hip’s bony abnormalities. This may be because surgery 
corrects the local mechanical issue (i.e. correction of the bony abnormalities until 
impingement free motion is obtained), but without resolution of the altered move-
ment strategies adopted pre-operatively.
Findings from the only large randomised controlled trial comparing hip 
arthroscopy and best conservative care for the treatment of FAI syndrome sup-
port the short-term efficacy of arthroscopic hip surgery [54]. However, patients 
in both groups reported significant improvements in hip-related quality of life at 
12-months, and the costs associated with surgery were higher than with conserva-
tive care [54]. Non-surgical treatments for FAI syndrome, such as exercise, activity 
adaptation and education, are globally recommended [48], and attractive given 
the relatively low harmful risks and associated costs. Identification of non-surgical 
interventions to reduce the burden of hip OA in its early stages, including FAI 
syndrome, is an important public health priority [55]. At present, conservative 
treatment effects for FAI syndrome are also modest [42, 56], likely due, in part, 
to a lack of understanding regarding the underlying mechanisms associated with 
clinical and structural decline.
3.2.1 Conservative care
Theoretically, an adequately designed, evidence-based, appropriately admin-
istered conservative management program may have the potential to alleviate 
symptoms, and in turn prevent disease progression, thus postponing or negating 
the need for surgery [56]. Current clinical practice entails combinations of physio-
therapist-led rehabilitation, education, and activity modification for the manage-
ment of FAI syndrome [48, 56]. There is little evidence from randomised control 
trials to guide conservative care for FAI syndrome, which means that conservative 
treatments are largely based on clinical theory and/or extrapolation of evidence 
from other clinical conditions.
Potential targets for conservative treatment include the abnormal movement 
patterns and hip muscle weakness seen in patients with FAI syndrome [31]. Gait 
assessment alone is unlikely to provide clear information to guide treatment of FAI 
syndrome. However, the biomechanical alterations at the hip joint and adjacent 
segments apparent during more demanding tasks (e.g. squatting, step ascent and 
descent) may be relevant in the clinical management of this patient population. 
Altered movement patterns in the form of altered hip joint biomechanics have been 
identified during tasks with similar demands in these patients post-operatively [36]. 
Pre-operative treatments addressing these biomechanical abnormalities may also 
have scope to improve surgical outcomes.
Retraining of deep hip muscle function (e.g. quadratus femoris, obturator inter-
nus) is a common objective of non-operative management [57] and post-operative 
rehabilitation [58] for FAI syndrome. Conservative care commonly targets deep 
hip external rotator muscle strengthening and neuromuscular retraining with the 
aim of improving dynamic hip joint stability [57]. Although experimental evidence 
suggests that activation of these deep muscles may contribute to dynamic stabil-
ity in a healthy hip [59], it is less clear if adaptations in neuromuscular control are 
associated with FAI syndrome. Cross-sectional data acquired during gait provide 
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preliminary evidence of the extent and nature of FAI-related changes to deep hip 
muscle activation [49]. However, an improved understanding of deep hip muscle 
function during more demanding, provocative tasks is needed to provide a compre-
hensive recommendation for retraining.
Hip strength assessment may be important in the clinical management of FAI 
syndrome. Evaluation of agonist/antagonist and/or between-limb strength ratios 
could be particularly beneficial clinically, as body size normalisation and control 
normative data for individual movement directions are not required. Reduced 
abduction strength in FAI patients [41] may have important implications as the 
abductor muscles control the position of the pelvis relative to the femur [60]. 
This is critical to prevent movement (i.e. contralateral pelvic drop) into a position 
that impinges the hip joint during single leg weight bearing tasks, such as those 
commonly required in sport where FAI syndrome has been identified (e.g. soc-
cer, dancing, football) [61]. Treatment programs targeting the primary abductor 
muscles may improve pelvic-femoral stability during single leg task performance 
in individuals with FAI syndrome, though any implications of such treatments for 
symptoms and joint structure are not yet clear.
3.2.2 Optimising treatment
Clinical interventions to restore normal musculoskeletal function around the 
hip joint may be beneficial, but future research is needed to determine whether 
these features can and should be changed, and whether this improves outcomes. 
Cam impingement has been proposed as a modifiable risk factor for hip OA [32]. 
Optimising treatments relies on the identification of novel treatment targets to slow 
femoral lesion progression and prolong the development of structural damage and 
early hip OA.
A critical step in the clinical management of individuals with FAI syndrome is 
to identify which biomechanical and neuromuscular features are: (i) positive and 
should be encouraged; (ii) negative and should be discouraged; and (iii) potentially 
positive prior to surgery to compensate for the abnormal morphology but should be 
a target for treatment following surgery to prevent further impairments. It would 
be precipitous to categorise these features without the support of longitudinal data. 
Nevertheless, it is abundantly clear that the widespread implications for FAI-related 
clinical practice depend on the appropriate classification of any modifiable targets 
for treatment.
The evaluation of conservative management programs, that include a range 
of techniques to modify joint motion/loading/function such as joint mobilisa-
tion techniques, hip bracing, and targeted exercise programs (including range of 
motion, strengthening, and/or neuromuscular retraining) are required on a range 
of outcomes in FAI syndrome (including any modifiable risk factors). Though the 
evidence underpinning these treatments is still in its infancy, the development of 
conservative treatments, including post-operative rehabilitation strategies and 
pre-operative training programs that aim to improve surgical outcomes, is a critical 
component as we move towards improving treatment outcomes.
4. Hip osteoarthritis
Hip OA is a major public health problem and affects one in four adults over their 
lifetime [62]. The condition substantially impairs quality of life and causes pain and 
physical dysfunction. Around the world, hip replacement surgery for hip OA is on 
the rise, and the burden of OA on society and health care cost will continue to rise 
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due to the ageing population and escalation in obesity rates [63]. Therefore, treat-
ments that reduce symptoms and delay the need for joint replacement are critical.
4.1 Biomechanical considerations in hip osteoarthritis
Kinematic and kinetic alterations are reported in people with hip OA compared 
to healthy controls. There is marked interest in hip joint loading as a culprit for 
disease progression, arguably due to the evidence in knee OA. Higher knee joint 
loading has been implicated in structural joint degeneration in middle-aged people 
at risk of early knee OA [64] and in individuals with established with knee OA [65]. 
However, few longitudinal studies have evaluated the association between hip joint 
biomechanics during gait and alterations in hip joint structure [66, 67]. A 12-month 
longitudinal study of women concluded that higher cumulative hip joint loading 
assessed as the number of steps per day, in the frontal plane, was associated with 
joint space narrowing at the hip joint [67]. However, there is insufficient evidence 
regarding which direction of loading magnitude change is detrimental for joint 
health (i.e. under- or over-loading). Recent investigations have highlighted the effect 
of sex, stage of disease and symptom severity on measures of joint loading, as well 
as the intricate relationships between these measures and hip joint load. Similar to 
other hip pathologies, hip OA is a heterogeneous disease, and exploration of patient 
and disease characteristics are needed to better understand moderators of hip joint 
load, a potential disease modifier. For the clinician, ‘joint loading’ is not examinable 
or visible in the clinical setting. However, the trunk and pelvis, together are major 
contributors to the centre of mass, the position of which (relative to the hip joint 
centre) influences hip joint loading. Thus, visual examination of trunk and pelvic 
kinematics during functional tasks is an important part of assessment.
4.1.1 Sex and joint loading
Measures of frontal plane loading appear to be dependent on sex. For example, 
in disease-free individuals the external hip adduction moment is typically greater 
in females as compared to males [68]. Between-sex differences in anatomy may 
explain these differences, at least in part. Females typically have a wider pelvis than 
males [69], which inherently increases the lateral distance of the centre of mass 
from the hip joint centre, and thus increases the hip adduction moment. However, 
any underlying anatomical differences appear secondary to disease stage when 
explaining difference in frontal plane moments. A series of cross-sectional studies 
indicate that between-sex differences in frontal plane loading are apparent in those 
with unilateral mild-to-moderate hip OA [70], while measures of hip joint loading 
are not different between men and women with end-stage hip OA [68]. The indirect 
effect of sex on hip joint loading earlier in the disease process was also detected in 
meta-regression analysis of a systematic review. Studies with a greater proportion 
of men demonstrated a greater average standardised mean difference for reduced 
frontal plane loading between people with hip OA compared to controls [71]. Given 
that loading may be relevant for disease progression, it may be clinically pertinent 
to consider sex-specific interventions for hip OA.
4.1.2 Stage of disease and joint loading
Measures of hip joint loading are also dependent on disease severity. A recent 
systematic review and meta-analysis of 13 studies suggests that people with hip 
OA appear to underload compared to controls [72]. Moreover, the sub-group 
analysis indicates that people awaiting total hip replacement (i.e. greater disease 
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severity) underload the hip joint compared to controls; whereas people with 
less severe disease have comparable measures of joint loading in the sagittal and 
frontal plane [73]. These observations are consistent with empirical investigations 
determining the influence of disease severity on measures of hip joint loading 
[71]. Understanding the effect of joint loading on joint structure and symptoms is 
imperative to guide conservative hip OA management.
4.1.3 Relevance of pain and symptoms
Slow walking speed is a risk factor for mortality [74] and chronic functional 
limitation in older adults [75]. A systematic review of 17 studies estimated that 
people with hip OA have a self-selected walking speed of 0.95 m/s, a markedly 26% 
slower than controls [76]. In light of critical walking speed estimates of 1.0 m/s 
[72], the observation that people with hip OA walk slower than critical walking 
speed estimates is alarming. Slower walking speed can be attributable to symptoms 
and a reduction in stride length in people with hip OA [76]. However, a recent 
cross-sectional study [73] investigating people with moderate radiographic hip 
OA with and without symptoms found that irrespective of symptoms, people with 
radiographic hip OA walk slower than disease-free individuals. These data question 
symptoms as a cause for reduced walking speed and instead, appear to reflect a 
longer-term adaptation hip joint degeneration. In addition to being an important 
marker of function [74, 75], walking speed also influences measures of hip joint 
loading. Investigators grapple with understanding whether alteration in measures 
of joint loading are predominately reflections of alterations in walking speed [77]. 
It appears that in addition to slower walking speed, neuromuscular adaptations are 
likely to underpin the reduction in hip joint loading in individuals with hip OA.
Evidence regarding pain during walking and how it influences movement 
strategies is emerging in OA literature [78]. In hip OA, the overall evidence supports 
the contention that people with hip OA, particularly at end-stage of the disease, 
underload during walking compared to controls [79]. The premise being that 
symptoms potentially cause people to walk slower. However, recent cross-sectional 
findings refute this logic [72], highlighting the complexities between symptoms and 
joint loading. In a study of people with unilateral mild-to-moderate radiographic 
hip OA, those who reported moderate pain during walking had higher frontal plane 
joint loading compared to people who reported less pain during walking [72]. These 
data suggest that people with mild or no pain during walking modified their gait 
biomechanics to exert lower frontal hip joint loading. Evidently, the relationship 
between symptoms and joint loading is intricate.
4.2 Conservative management for hip osteoarthritis
“What can I do myself to decrease OA symptoms and prevent the OA from getting 
worse?” These were prioritised as the most important questions by patients and 
health professionals in relation to hip and knee OA [80]. Treatments to reduce 
hip OA symptoms and delay the need for joint replacement are critical. Joint 
replacement is costly and is only reserved for end-stage disease when non-
surgical treatments are no longer effective. Current clinical guidelines [55, 81, 
82], including the recent update by the Royal Australian College of General 
Practitioners [83], emphasise that a healthy lifestyle consisting of regular 
exercise and weight management are the core management strategies for hip 
OA. Interestingly, there are no clinical trials for weight management in people 
with hip OA [83], and consequently the subsequent overview explores evidence 
for exercise in these individuals.
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Exercise is advised for all people with hip OA irrespective of age, disease sever-
ity, symptoms and co-morbidities [81]. A recent meta-analyses in people with hip 
OA identified 12 RCTs and showed small-to-modest beneficial effects of exercise 
on pain (standardised mean difference [SMD] −0.28, 95% CI: −0.45 to −0.10) and 
physical function (−0.34 SMD, 95% CI: −0.50 to −0.18) compared to no exercise 
[84]. Notably, two trials including 154 people scheduled for total hip replacement 
[85, 86], had large improvements in pain (−0.63 SMD, 95% CI: −0.95 to −0.30) 
and physical function (−0.71 SMD, 95% CI: −1.04 to −0.39) following 8–10 weeks 
of exercise. In addition to beneficial effects on symptoms, exercise can potentially 
delay total hip replacement. A long-term follow-up of a clinical trial found that 
exercise combined with patient education can potentially reduce the need for total 
hip replacement by 44% in people with hip OA [87].
Evidence strongly supports the use of exercise as treatment for hip OA symp-
toms and can potentially prevent disease progression. In line with high quality 
evidence and clinical guidelines, physiotherapists in the UK [88] and Australia [89] 
typically recommend exercise in the management of hip OA. However, knowledge 
on the specifics of exercise prescription is a recognised barrier to exercise uptake 
[90]. Reintahl [91] eloquently likens exercise prescription to drug prescription. For 
example, the physician determines the type of medication, the amount or intensity, 
the frequency of intake and the duration of use. Exercise prescription typically 
follows the frequency, intensity, type, time, volume and progression (FITT-VP) 
principles [92], but evidence on best exercise prescription is lacking for treatment 
of hip OA symptoms. Below, we provide an update on the current evidence for dos-
age and type of exercise.
4.2.1 Exercise dosage
Meta-analyses from trials with high compliance to the American College of 
Sports Medicine (ACSM) exercise guidelines with respect to dosage was −0.42 SMD 
(95% CI: −0.58 to −0.26) for pain, and studies with uncertain compliance to ACSM 
dosage was −0.05 SMD (95% CI, −0.35 to −0.25) for pain. Improvement in physical 
function of −0.41 SMD (95% CI −0.58, −0.24) was comparable to pain in trials with 
high compliance to the ACSM dosage guidelines while effect from trials with uncer-
tain compliance was −0.23 SMD (95% CI, −0.52, 0.06) [84]. These data support the 
prescription of exercise in accordance with ACSM guidelines, particularly in rela-
tion to pain. A Cochrane review revealed that patients with OA are confused about 
their cause of pain, and they do not know what they should and should not do, and 
as a consequence, they avoid activity for fear of causing harm [93]. Collectively, 
health professionals can use existing evidence to reassure patients about the value of 
exercise to safely manage symptoms.
4.2.2 Exercise type
All clinical trials to date include lower-limb strengthening [85, 86, 94–103], 
which is unsurprising given that hip and knee muscle weakness is widely estab-
lished in people with hip OA [104]. However, only a few clinical trials in people with 
hip OA include aerobic exercise [96, 101, 103]. People with hip OA often present 
with co-morbidities, such as poor cardiovascular fitness and low psychological well-
being, and these are associated with greater hip OA symptom severity  
[105, 106]. Aerobic exercise and muscle strengthening exercise address differ-
ent impairments associated with hip OA symptoms and the adaptations people 
experience are distinctly different for each exercise type. Aerobic exercise may 
enhance the effects of strengthening exercise on hip OA symptoms by targeting 
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cardiovascular fitness and psychological well-being [107]. In our own analysis, pain 
and physical function scores before and after exercise interventions in people with 
mild-to-moderate hip OA were sourced through publications and direct author 
contact. Changes in pain and physical function in studies that used a combination 
of aerobic and strengthening exercise are compared to those studies that used 
strengthening exercise only (Figure 3). This preliminary comparison provides 
support that greater effects on hip OA-related pain and physical dysfunction occur 
when a combination of aerobic and strengthening exercise is prescribed rather than 
strengthening exercise alone (Figure 3). Despite the clear rationale to support the 
premise that a combination of aerobic and muscle strengthening exercise could be 
more beneficial for hip OA symptoms then either exercise on its own, no clinical 
trials have directly tested this hypothesis.
5. Outcome measures
Measuring patient-specific outcomes following an intervention or over a 
course of care is important for clinical research and best evidence-based practice. 
Outcomes that are most meaningful from the patient’s perspective, such as those 
that measure symptoms of pain and physical function during activities of daily liv-
ing, are imperative [108, 109]. Other outcomes of impairments, such as strength, 
flexibility, range of motion are also important for clinicians and researchers to 
assess and monitor, but are more often used for clinical differential diagnosis or 
Figure 3. 
Change in pain (top plot) and physical function (bottom plot) in people with mild to moderate hip 
osteoarthritis after a combination of aerobic and strengthening exercise or strengthening exercise alone.
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prognosis and are usually secondary outcome measures to pain and physical func-
tion [109–111].
Measurement of pain and physical function are complex and cover multiple 
dimensions. For example, pain can be measured in multiple contexts includ-
ing intensity, duration, type and location. Physical functioning can not only be 
measured in many contexts but it also crosses multiple domains. According to the 
International Classification of Functioning, Disability and Health (ICF), physical 
function spans body functions and structure, activity and participation domains [112].
Many outcome tools for pain and physical function have been described for hip 
conditions and a selection of tools with the best level of measurement evidence is 
recommended [109]. Ideally, measure outcomes should be suitably valid, reliable 
and responsive to change. Known values of the minimum important difference 
(MID) are important for interpreting meaningful change and are useful to help set 
individual targets and goals with patients [113].
Patient outcomes can be measured using patient-reported outcome measures 
(PROMs) and performance-based tests measured by the clinician/researcher. Pain 
is usually measured with PROMs, such as pain scales and questionnaires, however 
physical functioning can be measured with both PROMs and performance-based 
tests. Performance-based tests reflect what patients can do rather than what they 
think they can do, which is usually captured with PROMs. When assessing physical 
function, it is recommended that both PROMs and performance-based tests are 
used as they can encapsulate different information as they test different constructs 
of function [114].
Patient outcomes can be measured using individual-specific, condition-specific 
and/or generic outcome tools. There are several condition-generic, individual-
specific PROMs that are useful in assessing and monitoring symptoms and function 
in people with a variety of hip conditions.
5.1 Condition-generic, individual-specific patient-reported outcome measures
The 11-point Numerical Pain Rating Scale (NPRS) can be used to track pain 
symptoms and can be customised to individual dimensions of pain. For example, 
average, current or greatest pain in the previous 24-hours or week can be mea-
sured ranging from 0 (no pain) to 10 (worst possible pain). Similarly, pain during 
an activity such as walking can be measured ranging from 0 (no pain on walking) 
to 10 (severe pain on walking). The MID for the NPRS (scale 0–10) in muscu-
loskeletal conditions ranges from 1.5 points (small change) to 3.5 points (large 
change) [115] and in hip OA is defined as a change in pain during walking of 1.8 
points [116].
The Patient-reported functional scale (PRFS) [117] assesses current level of dif-
ficulty associated with 3–5 activities that the individual identifies as being impor-
tant, each measured on an 11-point scale, where 0 is unable to perform the activity 
and 10 is able to perform the activity as normal. The MID for the PSFS ranges from 
1.3 points (small change) to 2.7 points (large change [115].
Patient-perceived change following an intervention over time can be measured 
on a Global Rating of Change (GROC) scale, customised to the outcome to be 
measured, and used by the patient to rate their perceived overall change as worse, 
no change or better. If worse, the patient is asked to indicate how much worse, from 
very much worse to slightly worse. If better, then they are asked how much better, 
from slightly better to very much better. An example is the 11-point GROC [118] 
with a change scale ranging from −5 to +5. The GROC scale can be very useful to set 
individual levels of acceptable change over a stated time frame and to set individual 
treatment goals [119].
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There are also several condition-generic PROMs useful for assessing quality 
of life in a variety of hip conditions. These include the Medical Outcome Study 36 
questions short form (SF-36) [120], the EuroQol (EQ-5D) [121] and the Assessment 
of quality of life (AQOL) [122]. Patient-specific quality of life questionnaires have 
also been developed for hip OA such as the Osteoarthritis Knee and Hip Quality of 
Life questionnaire (OAKHQOL) [123].
5.2 Condition-specific outcomes
The following sections will outline condition-specific PROMs and performance-
based tests used to measure pain and physical function in the hip conditions out-
lined previously in this chapter. Outcomes are selected based on available clinical 
practice guideline recommendations, measurement property evidence and reported 
use within clinical trials. A summary of the outcomes presented across the three 
hip conditions including the outcome domains, scoring method, and where known, 
MID values are provided in Table 1.
5.2.1 Gluteal tendinopathy
A number of valid and reliable measures used in recent clinical trials to measure 
change in pain and function in patients following corticosteroid injections and 
exercise [129] and recommended in a systematic review [130] are promising suit-
able outcomes for people with gluteal tendinopathies. These include the Victorian 
Institute of Sport Assessment-Gluteal tendon (VISA-G) questionnaire [131] that 
evaluates the severity of disability using 8 items about current pain and function. 
Regarding performance-based tests, the single-leg stance test with light fingertip 
support is useful to assess provocation of pain during a 30-second period. A report 
of pain over the greater trochanteric region indicates a positive test. This test has 
excellent sensitivity (100%) and specificity (97.3%), making it an ideal screening 
out test when pain is negative [2]. Additionally, the pain-free time and the time the 
patient can maintain a level pelvis in single-leg stance can also be recorded to mea-
sure change over time. Other performance-based tests include the single leg squat test 
where the ability to single leg squat as far as possible 5 times with the non-support leg 
out front and arms folded across the chest is rated on 5 criteria as good, fair or poor 
[132] and the star-excursion balance test that evaluates the ability to stand on one leg 
and reach the other leg into eight directions as far as possible [133].
5.2.2 Femoroacetabular impingement
A number of specifically designed, reliable and well-validated PROMs are 
recommended for measuring outcomes in people with FAI by an international, 
multidisciplinary consensus statement endorsed by 25 clinical societies worldwide 
[48]. The International Hip Outcome Tool (iHOT-33) is a patient-derived question-
naire designed to measure hip-related quality of life in young adults with non-
arthritic hip pain over four domains: symptoms and functional limitations; sports 
and recreational physical activities; job related concerns; and social, emotional and 
lifestyle concerns [124]. The hip and groin outcome score (HAGOS) was developed 
for physically active young to middle-aged adults [134] and contains 37 questions, 
covering six domains of pain; symptoms; physical function in daily living, sport 
and recreation; participation in physical function, sports and recreation, and hip 
and/or groin related QOL. The hip outcome score (HOS) [126] was developed to 
assess treatment outcomes of hip arthroscopy in young to middle-aged individuals 
and contains 28 questions, covering activities of daily living, and sport.
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Condition Outcome Items Scoring MID
Patient-reported outcomes
Numeric Pain 
Rating Scale 
(NPRS)
All Pain 1 0–10 scale
Higher scores 
indicate worst 
pain
1.5–3.5 points in 
musculoskeletal 
conditions [115]; 1.8 
points for hip OA 
[116]
Patient-
Specific 
Functional 
Scale (PSFS)
All Physical 
function
3–5 0–10 scale
Higher scores 
indicate higher 
function
1.3–2.7 points in 
musculoskeletal 
conditions [115]
Global Rating 
of Change 
(GROC) Scale
All Change in 
condition
1 Variable 
scales e.g. −5 
to +5, higher 
scores indicate 
improvement
Individualised e.g. 
moderately better/
somewhat worse
Victorian 
Institute 
of Sport 
Assessment-
Gluteal 
tendon 
(VISA-G)
GT Pain, 
physical 
function
8 0–100 mm VAS
Higher scores 
indicate less 
pain and higher 
function
International 
Hip Outcome 
Tool 
(iHOT-33)
FAI Pain, 
physical 
function, 
quality of 
life
33 0–100 mm 
VAS, where 100 
indicates better 
quality of life 
score
Between 6 mm [124] 
and 10 mm [125] in 
young adults after hip 
arthroscopy
Hip and 
Groin 
Outcome 
Score 
(HAGOS)
FAI Pain, 
physical 
function, 
quality of 
life
37 0–100 mm 
VAS where 100 
indicates no 
problems
Less than 10 mm 
(10%) on 
each subscale 
in young adults 
after hip arthroscopy 
[125]
Hip Outcome 
Score (HOS)
FAI Physical 
function
28 0–100 mm VAS
Higher scores 
on each 
subscale 
indicates 
higher levels 
of physical 
function
5-9 mm for ADL 
subscale; 6 mm for 
sports subscale in 
young adults after 
arthroscopic surgery 
[125, 126]
Western 
Ontario and 
McMaster 
Universities 
Osteoarthritis 
Index 
(WOMAC)
Hip OA Pain, 
stiffness, 
physical 
function
32 0–4 point scale
Higher scores 
on each of 
subscale 
indicate greater 
disability.
6/68 points on the 
physical function 
subscale in people 
with hip OA [127]
Hip disability 
and 
Osteoarthritis 
Outcome 
Score 
(HOOS)
Hip OA Pain, 
physical 
function, 
quality of 
life
40 0–4 point 
scale where 
0 indicates 
extreme 
symptoms and 
4 indicates no 
symptoms
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A clear recommendation of which performance-based tests should be used for 
this condition is yet to be made, however tests that are reliable and best discriminate 
between individuals with FAI and those without have been described [135]. This 
Condition Outcome Items Scoring MID
Performance-based tests
30-sec single 
leg stance
GT Pain, 
physical 
function
1 Pain free; hold 
pelvis level up 
to 30 s
Single leg 
squat test
GT Physical 
function
1 Rated as good, 
fair, poor
Star-
excursion 
balance test
GT Physical 
function, 
balance
1 Distance 
reached in 
centimetres 
normalised to 
leg length with 
larger distances 
indicating 
greater balance 
and higher 
physical 
function
Stair Climb 
test
All Physical 
function
1 Faster time 
in seconds 
indicates higher 
level of physical 
function
30-sec chair 
stand test
Hip OA Physical 
function
1 Great number 
of repetitions 
indicates higher 
level of physical 
function
2–3 repetitions in 
people with hip OA 
[128]
40-m fast 
paced walk 
test
Hip OA Physical 
function
1 Faster time 
in seconds or 
greater speed in 
metres/second 
indicates higher 
level of physical 
function
0.2–0.3 m/s in people 
with hip OA [128]
Timed Up 
and Go test
Hip OA 1 Faster time 
in seconds 
indicates higher 
level of physical 
function
0.8–1.4 s in people 
with hip OA [128]
6-minute 
walk test
Hip OA Physical 
function, 
aerobic 
capacity
1 Greater 
distance 
covered 
in metres 
indicates higher 
level of physical 
function and 
aerobic capacity
ADL, activities of daily living; FAI, femoroacetabular impingement; MID, minimum important difference; OA, 
osteoarthritis; VAS, visual analogue scale.
Table 1. 
Patient-reported outcome measures and performance-based tests for hip conditions.
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includes the 5-times sit-to-stand test where the time taken to transition from sitting 
to standing from a standard chair five times is recorded in seconds; and the stair 
ascend test where the time taken to ascend a flight of stairs as quickly as possible 
without using a handrail is recorded in seconds.
5.2.3 Hip osteoarthritis
Numerous clinical practice guidelines, for example [83, 108, 111], and recom-
mendations, for example [110, 136, 137] informed from high level measurement 
property evidence and expert consensus strongly recommend a number of 
condition-specific PROMs. The Western Ontario and McMaster Universities 
Osteoarthritis (WOMAC) Index [138] measures pain, stiffness and physical 
function The Hip disability and Osteoarthritis Outcome Score (HOOS) [139] 
consists of five subscales; pain, other symptoms, function in daily living, 
function in sport and recreation, and hip related quality of life. This scale 
incorporates items from the WOMAC scale so can also be extracted from this 
questionnaire.
The Osteoarthritis Research Society International (OARSI) recommend 
performance-based measures of physical function representing typical activities 
relevant to individuals diagnosed with hip or knee OA [136, 137]. Comprehensive 
descriptions, including set up, equipment, preparation (environment, partici-
pant, and tester), procedures, verbal instructions and scoring are available on the 
OARSI website: http://oarsi.org/research/physical-performance-measures along 
with videos of each recommended test. The full set includes five tests and the first 
three were recommended as the minimum core set: (i) 30 s chair stand test where 
the number of full stands a person can perform in a 30 s period is recorded in 
seconds; (ii) 40 m fast-paced walk test where the time taken to walk 4 × 10 m as 
quickly but as safely as possible is recorded in seconds which can be converted to 
speed recorded in metres per second; (iii) stair climb test where the time taken to 
ascend and descend a flight of stairs (with optional use of handrail) is recorded 
in seconds; (iv) timed up and go where the time taken to stand up from a standard 
chair with arm-rests, walk at regular pace to a line 3 m away, turn around and 
return to the seated position is recorded in seconds; and (v) six-minute walk test 
where the maximum possible distance walked in 6 min is recorded in metres 
covered.
6. Conclusion
Evidence supports exercise as a promising solution to the most important 
questions asked by patients with extra- and intra-articular hip pathologies and 
health professionals. Exercise can reduce hip symptoms and potentially prevent 
disease progression. Stakeholders, including but not limited to, health care 
professionals, research communities, consumer organisations, and local and 
national policy makers must make a deliberate effort to translate the positive 
message of exercise as a treatment for hip conditions. Research is ongoing to 
further empower patients and clinicians with evidence around best-prescription 
for exercise.
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